Epidemiology of Primary Headache and Its Associated Psychosocial Factors Amongst Undergraduate Medical Students: A Cross-Sectional Study From the Vidarbha Region
GHDx Entry last modified on: Mar 22, 2024
Prevalence
Dataset Records for Prevalence
Displaying 1 - 50 of 5036
Employees of the banking sector in Guizhou Province in China: prevalence of migraine, symptoms, disability and occupational risk factors
GHDx Entry last modified on: Mar 22, 2024
Burkina Faso Demographic and Health Survey 2021
Enquête Démographique et de Santé du Burkina Faso (EDSBF-V)
Survey:
Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint
GHDx Entry last modified on: May 12, 2022
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey'
Survey:
Epi surveillance
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021
Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021
Survey:
Epi surveillance
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Sep 13, 2022
Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey
Survey:
Epi surveillance
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study
GHDx Entry last modified on: Mar 22, 2024
United Kingdom - Northern Ireland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Aragon Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Hungary Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Montenegro Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Community of Madrid Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Galicia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Turkiye Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of migraine and tension-type headache among undergraduate medical students of Kathmandu Valley: A cross-sectional study
GHDx Entry last modified on: Mar 22, 2024
Bosnia and Herzegovina Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Cantabria Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Valencia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Tunisia - Sfax Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Migraine attacks among Lebanese university medical students: A cross sectional study on prevalence and correlations
GHDx Entry last modified on: Mar 22, 2024
Estonia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Romania Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Catalonia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Czechia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study
GHDx Entry last modified on: Mar 22, 2024
Iceland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - La Rioja Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Canary Islands Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Italy Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Serbia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Castille La Mancha Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Ukraine Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Primary Headaches and Physical Performance: A Professional Youth Female Soccer Team Study
GHDx Entry last modified on: Mar 22, 2024
Finland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Belgium Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Belarus Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Portugal Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
School-based online survey on chronic headache, migraine, and medication-overuse headache prevalence among children and adolescents in Japanese one city - Itoigawa Benizuwaigani study
GHDx Entry last modified on: Mar 22, 2024
Denmark Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Basque Country Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Subscribe